Coexpression cluster:C224: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 11:00, 17 September 2013
Full id: C224_clear_serous_pleomorphic_choriocarcinoma_mesothelioma_amniotic_renal
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
2.78345011903363e-05 | 0.0176192392534829 | 2 | 23 | GPCRs, Class B Secretin-like (Wikipathways):WP334 |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0032841 | calcitonin binding | 0.0180181142069971 |
GO:0006587 | serotonin biosynthetic process from tryptophan | 0.0180181142069971 |
GO:0008892 | guanine deaminase activity | 0.0180181142069971 |
GO:0016724 | oxidoreductase activity, oxidizing metal ions, oxygen as acceptor | 0.0180181142069971 |
GO:0004322 | ferroxidase activity | 0.0180181142069971 |
GO:0042428 | serotonin metabolic process | 0.0180181142069971 |
GO:0004948 | calcitonin receptor activity | 0.0180181142069971 |
GO:0042427 | serotonin biosynthetic process | 0.0180181142069971 |
GO:0004510 | tryptophan 5-monooxygenase activity | 0.0180181142069971 |
GO:0042435 | indole derivative biosynthetic process | 0.0180181142069971 |
GO:0046219 | indolalkylamine biosynthetic process | 0.0180181142069971 |
GO:0016722 | oxidoreductase activity, oxidizing metal ions | 0.0180181142069971 |
GO:0006568 | tryptophan metabolic process | 0.0180181142069971 |
GO:0001573 | ganglioside metabolic process | 0.0180181142069971 |
GO:0006878 | cellular copper ion homeostasis | 0.0180181142069971 |
GO:0007154 | cell communication | 0.0180181142069971 |
GO:0017046 | peptide hormone binding | 0.0180181142069971 |
GO:0031226 | intrinsic to plasma membrane | 0.0180181142069971 |
GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen | 0.0180181142069971 |
GO:0006586 | indolalkylamine metabolic process | 0.0180181142069971 |
GO:0042434 | indole derivative metabolic process | 0.0180181142069971 |
GO:0055070 | copper ion homeostasis | 0.0180181142069971 |
GO:0042430 | indole and derivative metabolic process | 0.0180181142069971 |
GO:0051384 | response to glucocorticoid stimulus | 0.0188354560439923 |
GO:0031960 | response to corticosteroid stimulus | 0.019091255349868 |
GO:0005375 | copper ion transmembrane transporter activity | 0.019091255349868 |
GO:0046658 | anchored to plasma membrane | 0.019091255349868 |
GO:0016491 | oxidoreductase activity | 0.019091255349868 |
GO:0031225 | anchored to membrane | 0.019479793407562 |
GO:0042136 | neurotransmitter biosynthetic process | 0.0200840578765452 |
GO:0006687 | glycosphingolipid metabolic process | 0.0226127014957497 |
GO:0006825 | copper ion transport | 0.0226127014957497 |
GO:0016597 | amino acid binding | 0.0226127014957497 |
GO:0005886 | plasma membrane | 0.0226127014957497 |
GO:0016524 | latrotoxin receptor activity | 0.0244558420830832 |
GO:0045762 | positive regulation of adenylate cyclase activity | 0.0244558420830832 |
GO:0031281 | positive regulation of cyclase activity | 0.0244558420830832 |
GO:0051349 | positive regulation of lyase activity | 0.0244558420830832 |
GO:0042562 | hormone binding | 0.0244558420830832 |
GO:0007568 | aging | 0.0244558420830832 |
GO:0042221 | response to chemical stimulus | 0.0259718531222645 |
GO:0006664 | glycolipid metabolic process | 0.0259718531222645 |
GO:0046915 | transition metal ion transmembrane transporter activity | 0.0262402933491107 |
GO:0042133 | neurotransmitter metabolic process | 0.0267409396897012 |
GO:0006672 | ceramide metabolic process | 0.0267409396897012 |
GO:0042401 | biogenic amine biosynthetic process | 0.0277896834696146 |
GO:0046519 | sphingoid metabolic process | 0.0279958952000989 |
GO:0007189 | G-protein signaling, adenylate cyclase activating pathway | 0.02801430006676 |
GO:0048545 | response to steroid hormone stimulus | 0.02801430006676 |
GO:0001633 | secretin-like receptor activity | 0.02801430006676 |
GO:0045761 | regulation of adenylate cyclase activity | 0.02801430006676 |
GO:0007584 | response to nutrient | 0.02801430006676 |
GO:0031279 | regulation of cyclase activity | 0.02801430006676 |
GO:0042398 | amino acid derivative biosynthetic process | 0.02801430006676 |
GO:0051339 | regulation of lyase activity | 0.02801430006676 |
GO:0044459 | plasma membrane part | 0.02801430006676 |
GO:0042446 | hormone biosynthetic process | 0.02801430006676 |
GO:0043176 | amine binding | 0.02801430006676 |
GO:0019239 | deaminase activity | 0.02801430006676 |
GO:0009072 | aromatic amino acid family metabolic process | 0.029417834829284 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 0.0301615508818891 |
GO:0007166 | cell surface receptor linked signal transduction | 0.0304408096550909 |
GO:0015082 | di-, tri-valent inorganic cation transmembrane transporter activity | 0.0318392749054169 |
GO:0008305 | integrin complex | 0.0318392749054169 |
GO:0055072 | iron ion homeostasis | 0.0318392749054169 |
GO:0006879 | cellular iron ion homeostasis | 0.0318392749054169 |
GO:0031667 | response to nutrient levels | 0.0335924896810473 |
GO:0007165 | signal transduction | 0.0336211191108662 |
GO:0009991 | response to extracellular stimulus | 0.0358616776243445 |
GO:0006665 | sphingolipid metabolic process | 0.0364141327106336 |
GO:0006576 | biogenic amine metabolic process | 0.039048333144058 |
GO:0009725 | response to hormone stimulus | 0.0395397183492577 |
GO:0001505 | regulation of neurotransmitter levels | 0.0400172800283473 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 0.042490656764607 |
GO:0007229 | integrin-mediated signaling pathway | 0.04276461186658 |
GO:0019933 | cAMP-mediated signaling | 0.04276461186658 |
GO:0042445 | hormone metabolic process | 0.04276461186658 |
GO:0006575 | amino acid derivative metabolic process | 0.0431681912286786 |
GO:0004872 | receptor activity | 0.0459792440025895 |
GO:0007160 | cell-matrix adhesion | 0.046261134576347 |
GO:0000041 | transition metal ion transport | 0.0469397938229353 |
GO:0031589 | cell-substrate adhesion | 0.0469397938229353 |
GO:0043235 | receptor complex | 0.0494953267747032 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
serous secreting cell | 2.55e-98 | 1 |
seromucus secreting cell | 4.52e-50 | 2 |
Ontology term | p-value | n |
---|---|---|
epithelium of female gonad | 2.55e-98 | 1 |
epithelium of gonad | 4.52e-50 | 2 |
female gonad | 5.70e-09 | 13 |
Ontology term | p-value | n |
---|---|---|
ovary epithelial cancer | 2.55e-98 | 1 |
clear cell adenocarcinoma | 2.74e-50 | 2 |
adenocarcinoma | 4.64e-17 | 25 |
female reproductive organ cancer | 6.71e-16 | 27 |
reproductive organ cancer | 6.74e-15 | 29 |
ovarian cancer | 2.00e-08 | 14 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 1.15531e-09 |
MA0004.1 | 0.0692917 |
MA0006.1 | 0.0119561 |
MA0007.1 | 0.318244 |
MA0009.1 | 0.196219 |
MA0014.1 | 0.000168144 |
MA0017.1 | 0.448072 |
MA0019.1 | 0.404253 |
MA0024.1 | 0.136013 |
MA0025.1 | 0.285416 |
MA0027.1 | 1.64023 |
MA0028.1 | 0.0150707 |
MA0029.1 | 0.146371 |
MA0030.1 | 1.3779 |
MA0031.1 | 0.709629 |
MA0038.1 | 0.934456 |
MA0040.1 | 0.893513 |
MA0041.1 | 0.651315 |
MA0042.1 | 1.55643 |
MA0043.1 | 0.57133 |
MA0046.1 | 1.05697 |
MA0048.1 | 0.205415 |
MA0050.1 | 0.0625073 |
MA0051.1 | 0.136921 |
MA0052.1 | 0.151713 |
MA0055.1 | 0.0238642 |
MA0056.1 | 0 |
MA0057.1 | 0.0228816 |
MA0058.1 | 0.0277371 |
MA0059.1 | 0.0826709 |
MA0060.1 | 0.151401 |
MA0061.1 | 0.526253 |
MA0063.1 | 0 |
MA0066.1 | 0.140731 |
MA0067.1 | 0.426099 |
MA0068.1 | 0.443875 |
MA0069.1 | 0.187175 |
MA0070.1 | 0.180428 |
MA0071.1 | 0.799731 |
MA0072.1 | 0.177746 |
MA0073.1 | 3.24791e-08 |
MA0074.1 | 0.582101 |
MA0076.1 | 0.00607824 |
MA0077.1 | 1.57436 |
MA0078.1 | 1.29026 |
MA0081.1 | 0.527155 |
MA0083.1 | 1.10194 |
MA0084.1 | 2.43655 |
MA0087.1 | 3.01884 |
MA0088.1 | 0.0663195 |
MA0089.1 | 0 |
MA0090.1 | 1.24341 |
MA0091.1 | 0.184212 |
MA0092.1 | 0.140498 |
MA0093.1 | 0.00192412 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.152048 |
MA0101.1 | 0.206844 |
MA0103.1 | 1.53126 |
MA0105.1 | 0.201142 |
MA0106.1 | 0.176444 |
MA0107.1 | 0.279781 |
MA0108.2 | 0.106251 |
MA0109.1 | 0 |
MA0111.1 | 0.123492 |
MA0113.1 | 1.14665 |
MA0114.1 | 0.264975 |
MA0115.1 | 0.365583 |
MA0116.1 | 0.0436546 |
MA0117.1 | 0.22006 |
MA0119.1 | 0.700896 |
MA0122.1 | 0.667475 |
MA0124.1 | 0.887885 |
MA0125.1 | 0.749804 |
MA0130.1 | 0 |
MA0131.1 | 0.0709376 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.15841 |
MA0136.1 | 0.146254 |
MA0139.1 | 0.137704 |
MA0140.1 | 0.492673 |
MA0141.1 | 0.520719 |
MA0142.1 | 0.641851 |
MA0143.1 | 1.6134 |
MA0144.1 | 1.75041 |
MA0145.1 | 0.00446344 |
MA0146.1 | 5.62407e-05 |
MA0147.1 | 0.00423696 |
MA0148.1 | 2.27337 |
MA0149.1 | 0.101583 |
MA0062.2 | 0.000441011 |
MA0035.2 | 0.490997 |
MA0039.2 | 1.69899e-05 |
MA0138.2 | 0.0646653 |
MA0002.2 | 0.127342 |
MA0137.2 | 0.841841 |
MA0104.2 | 0.00521186 |
MA0047.2 | 0.670694 |
MA0112.2 | 0.0775751 |
MA0065.2 | 0.0391677 |
MA0150.1 | 0.222744 |
MA0151.1 | 0 |
MA0152.1 | 0.273429 |
MA0153.1 | 0.260996 |
MA0154.1 | 0.362938 |
MA0155.1 | 0.000299618 |
MA0156.1 | 0.0552371 |
MA0157.1 | 2.02331 |
MA0158.1 | 0 |
MA0159.1 | 0.0464478 |
MA0160.1 | 0.720618 |
MA0161.1 | 0 |
MA0162.1 | 0.000349637 |
MA0163.1 | 0.00053335 |
MA0164.1 | 1.194 |
MA0080.2 | 0.0426084 |
MA0018.2 | 0.399835 |
MA0099.2 | 1.60754 |
MA0079.2 | 4.7011e-14 |
MA0102.2 | 0.616902 |
MA0258.1 | 0.116491 |
MA0259.1 | 0.201419 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
ESR1#2099 | 15 | 7.32585792765583 | 1.30709378936389e-09 | 1.17885637536593e-07 |
FOXA1#3169 | 17 | 2.9902243768183 | 3.01975007822677e-05 | 0.00062070395280442 |
GATA3#2625 | 7 | 3.02627959524511 | 0.00822411243133383 | 0.0324573207201025 |
NR3C1#2908 | 19 | 4.51567370305219 | 1.60437133710146e-08 | 1.16928777442805e-06 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data